
New drug could improve access to immunotherapies
A UK-led clinical trial has opened at The Christie NHS Foundation Trust in Manchester to test a new drug that could make immunotherapy safer and more accessible for patients with multiple myeloma. The trial, called TOPICAL, is led by The Christie NHS Foundation Trust and will take… Read More




